Piagam Penghargaan Program Pencegahan dan Penanggulangan COVID-19 (P2COVID-19) di Tempat Kerja

On January 13, 2023 PT Medifarma Laboratories submitted a proposal as a recipient of the Covid-19 Program (P2COVID-19) award in the workplace addressed to the Head of the West Java Province Manpower and Transmigration Office Cq the Head of the UPTD Labor Supervision Wilaya I Bogor. This award was issued in the context of the 2023 National K3 Month Award. The requirements and assessment criteria include:

  • P2 Covid-19 Program Policy
  • Socialization of the P2 Covid-19 Program
  • Implementation of the P2 Covid-19 Program
  • Business Continuity Planning and its implementation
  • Healthy Worker Movement
  • Stigma and Discrimination
  • Social Dialogue
  • Covid-19 risk assessment
  • Organizational structure and Team P2 Covid
  • Allocation of special funds in the implementation of the P2 Covid-19 program
  • Recording and Reporting
  • Evaluation of the performance of the Covid-19 team, level of knowledge and behavior of workers, facilities and infrastructure for prevention and control of Covid-19
  • Community Service

Based on the assessment criteria After verification with the implementation of the P2 Covid-19 program in the workplace, based on the Decree of the Minister of Manpower of the Republic of Indonesia No. 97 of 2023 dated June 9, 2023 PT Medifarma Laboratories was designated as an Award Recipient Company for the Prevention and Control of COVID-19 Program in the workplace with the PLATINUM category.